Wellbiotec Valuation

Is A010600 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A010600 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate A010600's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A010600's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A010600?

Key metric: As A010600 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A010600. This is calculated by dividing A010600's market cap by their current revenue.
What is A010600's PS Ratio?
PS Ratio	0.7x
Sales	₩72.79b
Market Cap	₩49.55b

A010600 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.6x
Enterprise Value/EBITDA	-2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does A010600's PS Ratio compare to its peers?

The above table shows the PS ratio for A010600 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.4x
A008370 Wonpoong	0.7x	n/a	₩54.1b
A263020 DK&DLtd	0.5x	n/a	₩48.1b
A079980 Huvis	0.09x	n/a	₩83.4b
A130500 GH Advanced Materials	0.4x	n/a	₩38.5b
A010600 Wellbiotec	0.7x	n/a	₩49.6b

Price-To-Sales vs Peers: A010600 is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.4x).

Price to Sales Ratio vs Industry

How does A010600's PS Ratio compare vs other companies in the KR Luxury Industry?

5 Companies	Price / Sales	Estimated Growth	Market Cap
A016450 Hansae Yes24 Holdings	0.06x	n/a	US$125.05m
A079980 Huvis	0.09x	n/a	US$59.48m
A007980 TP	0.06x	n/a	US$46.38m
A002070 Vivien	0.1x	n/a	US$15.87m

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: A010600 is expensive based on its Price-To-Sales Ratio (0.7x) compared to the KR Luxury industry average (0.4x).

Price to Sales Ratio vs Fair Ratio

What is A010600's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A010600 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.7x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate A010600's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.